145 related articles for article (PubMed ID: 16733797)
1. Induction of G2/M phase arrest and apoptosis by a novel enediyne derivative, THDA, in chronic myeloid leukemia (K562) cells.
Wu ZZ; Chien CM; Yang SH; Lin YH; Hu XW; Lu YJ; Wu MJ; Lin SR
Mol Cell Biochem; 2006 Nov; 292(1-2):99-105. PubMed ID: 16733797
[TBL] [Abstract][Full Text] [Related]
2. Induction of G2/M phase arrest and apoptosis by a novel enediyne derivative, THDB, in chronic myeloid leukemia (HL-60) cells.
Lu YJ; Yang SH; Chien CM; Lin YH; Hu XW; Wu ZZ; Wu MJ; Lin SR
Toxicol In Vitro; 2007 Feb; 21(1):90-8. PubMed ID: 17064874
[TBL] [Abstract][Full Text] [Related]
3. JNK and ERK mitogen-activated protein kinases mediate THDA-induced apoptosis in K562 cells.
Yang SH; Wu ZZ; Chien CM; Lo YH; Wu MJ; Chang LS; Lin SR
Cell Biol Toxicol; 2008 Aug; 24(4):291-302. PubMed ID: 17934787
[TBL] [Abstract][Full Text] [Related]
4. Induction of G2/M phase arrest by squamocin in chronic myeloid leukemia (K562) cells.
Lu MC; Yang SH; Hwang SL; Lu YJ; Lin YH; Wang SR; Wu YC; Lin SR
Life Sci; 2006 Apr; 78(20):2378-83. PubMed ID: 16310807
[TBL] [Abstract][Full Text] [Related]
5. NOAD, a novel nitric oxide donor, induces G2/M phase arrest and apoptosis in human hepatocellular carcinoma Bel-7402 cells.
Liu L; Wang D; Wang J; Ji H; Zhang Y
Toxicol In Vitro; 2015 Oct; 29(7):1289-97. PubMed ID: 26001517
[TBL] [Abstract][Full Text] [Related]
6. Involvement of c-jun N-terminal kinase in G2/M arrest and caspase-mediated apoptosis induced by cardiotoxin III (Naja naja atra) in K562 leukemia cells.
Yang SH; Chien CM; Chang LS; Lin SR
Toxicon; 2007 Jun; 49(7):966-74. PubMed ID: 17368702
[TBL] [Abstract][Full Text] [Related]
7. Induction of G2/M arrest, endoreduplication, and apoptosis by actin depolymerization agent pextenotoxin-2 in human leukemia cells, involving activation of ERK and JNK.
Moon DO; Kim MO; Kang SH; Lee KJ; Heo MS; Choi KS; Choi YH; Kim GY
Biochem Pharmacol; 2008 Aug; 76(3):312-21. PubMed ID: 18571148
[TBL] [Abstract][Full Text] [Related]
8. Indirubin-3'-monoxime promotes autophagic and apoptotic death in JM1 human acute lymphoblastic leukemia cells and K562 human chronic myelogenous leukemia cells.
Lee MY; Liu YW; Chen MH; Wu JY; Ho HY; Wang QF; Chuang JJ
Oncol Rep; 2013 May; 29(5):2072-8. PubMed ID: 23468088
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Zhang GS; Liu DS; Dai CW; Li RJ
Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
[TBL] [Abstract][Full Text] [Related]
10. E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agents.
Stiewe T; Parssanedjad K; Esche H; Opalka B; Pützer BM
Cancer Res; 2000 Jul; 60(14):3957-64. PubMed ID: 10919674
[TBL] [Abstract][Full Text] [Related]
11. Effects of cardiotoxin III on expression of genes and proteins related to G2/M arrest and apoptosis in K562 cells.
Yang SH; Tsai CH; Lu MC; Yang YN; Chien CM; Lin SF; Lin SR
Mol Cell Biochem; 2007 Jun; 300(1-2):185-90. PubMed ID: 17149543
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis and erythroid differentiation of human chronic myelogenous leukemia K562 cells by low concentrations of lidamycin.
Zhang C; Guo LY; Mu D; Gong JH; Chen J
Oncol Rep; 2019 Jan; 41(1):475-482. PubMed ID: 30542729
[TBL] [Abstract][Full Text] [Related]
13. Induction of G(2)/M phase arrest and apoptosis by a new synthetic anti-cancer agent, DW2282, in promyelocytic leukemia (HL-60) cells.
Piao W; Yoo J; Lee DK; Hwang HJ; Kim JH
Biochem Pharmacol; 2001 Dec; 62(11):1439-47. PubMed ID: 11728380
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
[TBL] [Abstract][Full Text] [Related]
15. The importance of drug scheduling and recovery phases in determining drug activity. Improving etoposide efficacy in BCR-ABL-positive CML cells.
Liu WM; Lawrence AJ; Joel SP
Eur J Cancer; 2002 Apr; 38(6):842-50. PubMed ID: 11937320
[TBL] [Abstract][Full Text] [Related]
16. Early caspase activation in leukemic cells subject to etoposide-induced G2-M arrest: evidence of commitment to apoptosis rather than mitotic cell death.
Sleiman RJ; Stewart BW
Clin Cancer Res; 2000 Sep; 6(9):3756-65. PubMed ID: 10999770
[TBL] [Abstract][Full Text] [Related]
17. Selective induction of G2/M arrest and apoptosis in HL-60 by a potent anticancer agent, HMJ-38.
Yang JS; Hour MJ; Kuo SC; Huang LJ; Lee MR
Anticancer Res; 2004; 24(3a):1769-78. PubMed ID: 15274354
[TBL] [Abstract][Full Text] [Related]
18. The novel synthesized 2-(3-(methylamino)phenyl)-6-(pyrrolidin-1-yl)quinolin-4-one (Smh-3) compound induces G2/M phase arrest and mitochondrial-dependent apoptotic cell death through inhibition of CDK1 and AKT activity in HL-60 human leukemia cells.
Huang SM; Yang JS; Tsai SC; Chen MH; Hsu MH; Lin HY; Chou LC; Chinag JH; Lee KH; Huang LJ; Kuo SC
Int J Oncol; 2011 May; 38(5):1357-64. PubMed ID: 21344160
[TBL] [Abstract][Full Text] [Related]
19. Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly(ADP-ribose) polymerase cleavage.
Nabha SM; Mohammad RM; Dandashi MH; Coupaye-Gerard B; Aboukameel A; Pettit GR; Al-Katib AM
Clin Cancer Res; 2002 Aug; 8(8):2735-41. PubMed ID: 12171907
[TBL] [Abstract][Full Text] [Related]
20. A Subpopulation of the K562 Cells Are Killed by Curcumin Treatment after G2/M Arrest and Mitotic Catastrophe.
Martinez-Castillo M; Bonilla-Moreno R; Aleman-Lazarini L; Meraz-Rios MA; Orozco L; Cedillo-Barron L; Cordova EJ; Villegas-Sepulveda N
PLoS One; 2016; 11(11):e0165971. PubMed ID: 27832139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
